These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 10870123
1. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization. Olavarria E, Parker S, Craddock C, Philpott N, Tiniakou M, Chase A, Kanfer E, Apperley JF, Goldman JM. Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123 [Abstract] [Full Text] [Related]
2. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon. Hernández-Boluda JC, Carreras E, Cervantes F, Marín P, Arellano-Rodrigo E, Rovira M, Solé F, Lloveras E, Espinet B, Ocejo A, Montserrat E. Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461 [Abstract] [Full Text] [Related]
3. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F. Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [Abstract] [Full Text] [Related]
4. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy. Russo D, Martinelli G, Montefusco V, Amabile M, Rosti G, Marin L. Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048 [No Abstract] [Full Text] [Related]
5. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome]. Meng FY, Sun J, Liu QF, Xu D, Yang LJ, Song LL, Liu XL, Xu B, Zhou SY. Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896 [Abstract] [Full Text] [Related]
6. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G. Haematologica; 1997 Dec; 82(3):291-6. PubMed ID: 9234574 [Abstract] [Full Text] [Related]
7. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related]
8. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3. Aulitzky WE, Neubauer A, Kolbe K, Schneller F, Busemann C, Schleiermacher E, Peschel C, Siegert W, Huber C, Huhn D. Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707 [Abstract] [Full Text] [Related]
9. Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate. Perseghin P, Gambacorti-Passerini C, Tornaghi L, Dassi M, Pioltelli P, Parma M, Colnaghi F, Giudici G, Elli E, Fumagalli M, Ponchio L, Biondi A, Pogliani EM. Transfusion; 2005 Jul; 45(7):1214-20. PubMed ID: 15987369 [Abstract] [Full Text] [Related]
10. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon. McBride NC, Cavenagh JD, Newland AC, Lillington DM, Murrell C, Kelsey SM. Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726 [Abstract] [Full Text] [Related]
11. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy. Singhal S, Mehta J, Desikan K, Siegel D, Singh J, Munshi N, Spoon D, Anaissie E, Ayers D, Barlogie B. Bone Marrow Transplant; 1999 Jul; 24(1):13-7. PubMed ID: 10435728 [Abstract] [Full Text] [Related]
12. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia. Broughton CM, Sherrington P, Pender NT, Clark RE. Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569 [Abstract] [Full Text] [Related]
13. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia. Mehta J, Mijović A, Powles R, Pagliuca A, Singhal S, Czepulkowski B, Swansbury GJ, Treleaven J, Mufti GJ. Bone Marrow Transplant; 1996 Jan; 17(1):25-9. PubMed ID: 8673050 [Abstract] [Full Text] [Related]
14. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia. Boqué C, Petit J, Sarrá J, Cancelas JA, Muñoz J, Español JI, de la Banda E, Aventin A, Berlanga J, Ferrá C, Amill B, Torrico C, Azqueta C, Llucià M, García J, Grañena A. Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840 [Abstract] [Full Text] [Related]
15. [Collection of hematopoietic progenitor cells from healthy donors]. Bojanić I, Cepulić BG, Mazić S. Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352 [Abstract] [Full Text] [Related]
16. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH. Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886 [Abstract] [Full Text] [Related]
17. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis. Sureda A, Petit J, Brunet S, Boqué C, Aventín A, Martino R, González JR, Amill B, Larriba I, Blanco A, Martín-Henao GA, Sierra J, Grañena A. Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636 [Abstract] [Full Text] [Related]
18. Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens. Deininger M, Pönisch W, Krahl R, Leiblein S, Edel E, Lange T, Fiedler F, Freund M, Franke A, Pasold R, von Grünhagen U, Herold M, Dölken G, Hoffmann FA, Uhle R, Schultze W, Steglich J, Schwarzer A, Richter P, Winkelmann C, Kettner E, Dachselt K, Subert R, Schwalbe E, Doepper J, Helbig W, Niederwieser D, East German Study Group Haematology/Oncology (OSHO). Bone Marrow Transplant; 2001 Jun; 27(11):1125-32. PubMed ID: 11551022 [Abstract] [Full Text] [Related]
19. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia. Frassoni F, Giordano D, Podestà M, Piaggio G, Benvenuto F, Pitto A, Figari O, Dejana A, Lerma E, Vassallo F, Sessarego M, Carella A. Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704 [Abstract] [Full Text] [Related]
20. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS. Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507 [Abstract] [Full Text] [Related] Page: [Next] [New Search]